Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
about
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.Gabapentin or pregabalin for the prophylaxis of episodic migraine in adultsValproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adultsAntiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adultsTopiramate for the prophylaxis of episodic migraine in adultsPreventive pharmacologic treatments for episodic migraine in adultsEvidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache SocietyRecent advances in migraine therapyThe Migraine-Stroke ConnectionRoads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine PathologyNew players in the preventive treatment of migraineA review of frovatriptan for the treatment of menstrual migraineRepurposing of approved cardiovascular drugsSpotlight on frovatriptan: a review of its efficacy in the treatment of migraineAssociation of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraineInterventions for migraine prophylaxis: protocol of an umbrella systematic review and network meta-analysisEffectiveness of preventive and treatment interventions for primary headaches in the workplace: A systematic review of the literature.Migraine and its psychiatric comorbidities.Clinical aspects of headache in HIV.Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.Obesity, abdominal obesity and migraine: a cross-sectional analysis of ELSA-Brasil baseline data.Genetic variation in the beta-2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health-related quality of lifePersistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysisPURLs: Consider melatonin for migraine prevention.Linear headache: a recurrent unilateral head pain circumscribed in a line-shaped areaEfficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines.How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT).An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine.Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trialRefractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.Use of common migraine treatments in breast-feeding women: a summary of recommendations.Pediatric issues in sports concussionsBreastfeeding and migraine drugs.Traditional Chinese patent medicine for prophylactic treatment of migraine: a meta-analysis of randomized, double-blind, placebo-controlled trials.Late-life migraine accompaniments: A narrative review.Comparison of parenteral treatments of acute primary headache in a large academic emergency department cohortTherapeutic antibodies against CGRP or its receptorA Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.Are migraine and tension-type headache diagnostic types or points on a severity continuum? An exploration of the latent taxometric structure of headache.
P2860
Q24186656-710A3C1D-927F-45F7-BE8F-0E34D01DF8D9Q24201830-EE93F63B-9C5A-4680-8C48-7E6FF97C2880Q24201842-BAA31D38-E249-4391-8958-E4B495B01352Q24201845-894A447E-90A7-4B46-90E3-C3060BE0D652Q24201849-C50B4485-6619-4294-BDFA-4189633E7E9CQ24630992-17850046-C27B-4BDF-9251-63208D44E220Q24633546-263A20A1-E94B-483D-9FE8-7F3E279CBCE5Q26743537-E0A22853-5BC9-4AD3-A289-807D4BDE8B20Q26747260-83136DA0-AB4F-4CBD-8AF6-C9DD58EE8741Q26752538-396F5495-6606-4D84-952C-FF044E38697EQ26778185-F5195E1A-AD0F-4E69-A434-3A79E76D8860Q27025002-A4C0E2FC-CFF8-4742-844D-CAFA5392F6B6Q28074453-40D78FD9-B012-446E-A8F5-CD695317F120Q28078673-310123FF-8778-4410-9E10-8E672C2785B3Q28081399-167A48C0-08F9-41ED-A115-4BB2218EA1E1Q28647495-AB1428F2-809F-4F6F-9D4E-67D1600BF03FQ30251848-C3F87A5B-6A4A-4439-9011-56F244C55B1EQ30251982-0F2AEFEE-8083-446E-BAC7-5C2E8A9910CBQ30805163-E2B48C56-9C88-4D41-9D90-017C9FD00110Q30831647-784632A2-2DD7-4D64-B327-00C3069FEF46Q30842241-F21C3592-E75E-4B2E-A2D3-00A39C760CB2Q33597755-39099348-BE55-40AB-B7C7-5687FA06CCE5Q33605478-9EBAA0F2-8FE4-413D-B335-55700F6BC5EFQ33688426-9520B5B0-5268-4BC6-84BE-28CB7BEC8A2EQ33832194-66D6D2F3-0292-4BCA-9469-423FA61BC360Q33958060-9C310923-A69D-4C71-863B-0DA79FCA7FE7Q34279280-0E775C52-9EE6-4B35-A111-E2CFB17B4DCAQ34303798-4DC8BF56-2551-4C0A-BB64-D60454736C68Q34455231-5E4BC2E5-904F-4132-B284-7F0CD87892E1Q34473830-13D293F5-C5BE-4064-ABEC-9C2DC18ACAC3Q34544375-87351BDD-A46F-4FEC-830B-C1CA325010A7Q34610187-F4BCE0CD-9259-4928-B44B-71C54FC24F49Q34758337-9A80078A-8981-4CC8-AE45-53EE8D3FEABCQ35250900-7EBDE01F-D3D4-4380-9BA6-E4A5B3365378Q35367066-34FA9E5F-7496-44D2-A6B1-D22B4916A0F7Q35518633-B6C02AF8-CB6B-4B20-A7B0-02AFD2905121Q35563608-E4E59DC6-6DFF-4C97-99C0-393132D8A45BQ35684794-4B14C837-B9EA-498F-8250-CC3CCDC52B97Q35690766-1CC8BB9B-7FAC-4A48-9ECB-BDF558CB34EFQ35914485-D35DFBEF-BE30-4BC3-A4CB-ADEFD4262D25
P2860
Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Evidence-based guideline updat ...... the American Headache Society
@ast
Evidence-based guideline updat ...... the American Headache Society
@en
Evidence-based guideline updat ...... the American Headache Society
@nl
type
label
Evidence-based guideline updat ...... the American Headache Society
@ast
Evidence-based guideline updat ...... the American Headache Society
@en
Evidence-based guideline updat ...... the American Headache Society
@nl
prefLabel
Evidence-based guideline updat ...... the American Headache Society
@ast
Evidence-based guideline updat ...... the American Headache Society
@en
Evidence-based guideline updat ...... the American Headache Society
@nl
P2093
P2860
P921
P3181
P1433
P1476
Evidence-based guideline updat ...... the American Headache Society
@en
P2093
D W Dodick
S D Silberstein
P2860
P304
P3181
P356
10.1212/WNL.0B013E3182535D20
P407
P577
2012-04-24T00:00:00Z